Notes
HPA medications
Content of the notes (5)
Page 1
Aspirin
Trade names:
Aspro - Disprin - Astrix - Solprin
Chemical name:
Acetylsalicylic Acid
Therapeutic class:
NSAID/Antipyretic
Pharmacological class:
Salicylates
Indications:
Inflammatory disorders including osteoarthritis & rheumatoid arthritis
Mild - moderate pain
Fever
Prophylaxis of transient ischaemic attacks & MI
Actions:
Produces analgesia and reduces inflammation and fever by inhibiting the production of prostaglandins
Decreases platelet aggregation
Therapeutic effects:
Analgesia
Reduction of inflammation
Reduction of fever
Reduced incidence of transient ischaemic attacks & MI
Pharmacokinetics:
ABSORPTION: Well absorbed from the upper small intestine. Absorption from enteric-coated SR preps may be unreliable. Rectal absorption is slow and variable.
DISTRIBUTION: Rapidly and widely distributed; crosses the placenta & enters breast milk
METABOLISM + EXCRETION: Extensively metabolised by the liver, inactive metabolites excreted by the kidneys.
Half-life: 2 -3 hrs for low doses, 15 - 30 for high doses because of liver metabolism saturation
Contraindications/precautions:
Hypersensitivity to aspirin or other salicylates
Bleeding disorders or thrombocytopenia (low platelet count)
History of GI bleeding or ulcer disease
Asthma
Adverse reactions/ side effects:
EENT: tinnitus GI: bleeding, dyspepsia, epigastric distress, N + V, abdo pain HEP: toxicity HAEM: anemia, hemolysis, SKIN: rash, urticaria
Interactions:
May ^ the risk of bleeding with warfarin, heparins, heparin-like agents, thrombolytic agents
Assessment:
Pain assessment
Fever
Lab tests: monitor hepatic function if symptoms of hepatotoxicity occur or during long term use
Patient/family education:
Advise patient to report: tinnitus, bleeding of gums, easy bruising, black tarry stools, or fever > 3 days
Page 2
Insulin (short-acting)
Trade names:
Actrapid
Chemical name:
Insulin
Therapeutic class:
BGL regulator
Pharmacological class:
Endocrine
Indications:
Type 1 diabetes
Type 2 diabetes inadequately controlled with diet, exercise and oral antidiabetic drugs, and where oral antidiabetic drugs cannot be used
Actions:
Increase or restore ability to metabolise glucose by enhancing cellular glucose uptake
inhibit endogenous glucose output and lipolysis.
Therapeutic effects:
BGL reduction
Pharmacokinetics:
ABSORPTION: Well absorbed from subcutaneous abdominal injection, slower to absorb in other injection sites
DISTRIBUTION: Does not cross the placenta or enter breast milk - destroyed in the GIT
METABOLISM + EXCRETION: Extensively metabolised by the liver, inactive metabolites excreted by the kidneys.
Half-life: Varies with each preparation - metabolised at a cellular level
Contraindications/precautions:
Although insulin does not end up in breastmilk, it can cause a decrease in milk production
Adverse reactions/ side effects:
ENDO: hypoglycaemia, ketoacidosis,
Interactions:
Caution should be used when taking other drugs that decrease glucose levels in the blood such as MAOIs, betablockers, salicylates or alcohol. Dose should be adjusted accordingly. Betablockers can also interfere with signs of hypoglycaemia
Assessment:
BGL level pre and post
Baseline vital signs to assist with detecting hypo/hyperglycaemia
Monitor person's response to administration
Patient/family education:
Diabetes education: signs of hypoglycaemia, diet, exercise. Consider referral to diabetes education.
Page 3
Ampicillin
Trade names:
Ampicyn - Ibimycin - Austrapen
Chemical name:
Aminobenzylpenicillin
Therapeutic class:
Antiinfective
Pharmacological class:
Antibiotic - Penicillin
Indications:
Chronic bronchitis
CAP (community acquired pneumonia)
Gonnococal infection
Broad spectrum
Actions:
Bactericidal; interfere with bacterial cell wall peptidoglycan synthesis by binding to penicillin-binding proteins, eventually leading to cell lysis and death.
Therapeutic effects:
Reduction in bacterial infection
Pharmacokinetics:
ABSORPTION: Not well absorbed in GIT - best given via IV for optimal absorption
DISTRIBUTION: Does cross placenta and into breastmilk - however is said to be safe
METABOLISM + EXCRETION: partially metabolised by the liver, the remainder by the kidneys in urine.
Half-life: 1 - 11 hours
Contraindications/precautions:
Penicillin allergy!
Those with heart failure or on sodium restriction - high levels of sodium
Immunocompromised individuals = high incidence of rash
Renal impairment
Adverse reactions/ side effects:
Skin: rash GIT: diarrhoea, N + V, CNS: neurotoxicity at high doses/ renal impairment
Interactions:
Caution should be used when taking tetracyclines or aminoglycosides. Tetracyclines will decrease effectiveness of penicillin and penicillins will decrease the effectiveness of aminoglycosides.
Assessment:
Obtain specimen for culture
Baseline vital signs
Monitor person's response to administration
Patient/family education:
Tell patients to report adverse effects and the drink lots of fluids, and keep up nutrition.
Page 4
Cephazolin
Trade names:
Cefazolin - Kefzol
Chemical name:
Cephazolin Sodium
Therapeutic class:
Antiinfective
Pharmacological class:
Antibiotic - Cephalosporin
Indications:
Staphylococcal and streptococcal infections in people with mild-to-moderate penicillin allergy
Surgical prophylaxis
UTI
Actions:
Interfere with bacterial cell wall peptidoglycan synthesis by binding to penicillin-binding proteins, eventually leading to cell lysis and death; bactericidal.
Therapeutic effects:
Reduction in bacterial infection
Pharmacokinetics:
ABSORPTION: Not well absorbed in GIT - best given via IV for optimal absorption
DISTRIBUTION: Does cross placenta and into breastmilk - however is said to be safe
METABOLISM + EXCRETION: Excreted unchanged in urine
Half-life: 1.8 hours
Contraindications/precautions:
Some people who are allergic to penicillins are also allergic to cephalosporins
Those with heart failure or on sodium restriction - high levels of sodium
Immunocompromised individuals = high incidence of rash
Renal impairment
Adverse reactions/ side effects:
Skin: rash GIT: diarrhoea, N + V, CNS: neurotoxicity at high doses/ renal impairment
Interactions:
N/A
Assessment:
Obtain specimen for culture
Baseline vital signs
Monitor person's response to administration
Patient/family education:
Tell patients to report adverse effects and the drink lots of fluids, and keep up nutrition.
Page 5
Information
- Description
- Nursing SFE Nursing Note on HPA medications, created by Em J on 03/06/2018.
- Created by
- Em J
- Views
- 11
- Rating